Chandrashekhar Athare: EHA 2026 Concludes with Lasting Impact and New Collaborations
Chandrashekhar Athare, Associate Director at Innomagine Consulting Private Limited, shared a post on LinkedIn:
“As EHA 2026 comes to a close, I would like to express my gratitude to the organizers, speakers, exhibitors, and fellow attendees for an excellent congress in Stockholm.
Over the past few days, I had the opportunity to learn about the latest advancements in hematology, attend inspiring scientific sessions, and connect with professionals from across the global healthcare and life sciences community.
The insights gained, conversations shared, and connections made will undoubtedly contribute to future collaborations and continued learning.
A special thanks to everyone who took the time to connect and exchange ideas.
I look forward to staying in touch and continuing these discussions beyond the congress.
Until next time—looking forward to EHA 2027!”
Stay updated with Hemostasis Today.
-
Sep 29, 2026, 19:00Caitlin Raymond: Can Artificial Blood Solve Blood Supply Shortages?
-
Sep 29, 2026, 18:51Chaza Alaji: Dyslipidemia, Thrombosis and the DIC Diagnostic Trap
-
Sep 29, 2026, 17:31Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
-
Sep 29, 2026, 17:13Nicholas Lang։ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge